Trial record 1 of 1 for:
baumgartner and hearing loss
Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children
This study has suspended participant recruitment.
(Current IRB stipulations require more detailed updates. Not related to current patient safety or non-compliance issues.)
Sponsor:
Memorial Hermann Healthcare System
Collaborators:
Cord Blood Registry
Speech Therapists for Children
The University of Texas Health Science Center, Houston
M.D. Anderson Cancer Center
Baylor College of Medicine
The Methodist Hospital System Research Institute - Houston
Information provided by:
Memorial Hermann Healthcare System
ClinicalTrials.gov Identifier:
NCT01343394
First received: April 25, 2011
Last updated: July 19, 2012
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | April 2015 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |